Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
Gabriel Osorio-Mazilli

MYSTERIOUS: Missed the hims hers rally clover health could be next - What They Never Told You

Shares of Hims & Hers Health Inc. (NYSE: HIMS) have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right back, crashing down to as low as $36 per share. Now, this is where most investors would throw in the towel and forget why they bought the stock in the first place.

This is alright; it’s human nature to still be convinced about a company’s story after such a steep decline. However, the market has shown these recent sellers that there are still some valid reasons for investors to keep hanging on to their shares of Hims & Hers stock for the long haul.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.